Cargando…

Nanoparticle-Mediated In Situ Molecular Reprogramming of Immune Checkpoint Interactions for Cancer Immunotherapy

[Image: see text] Immune checkpoint blockade involves targeting immune regulatory molecules with antibodies. Preclinically, complex multiantibody regimes of both inhibitory and stimulatory targets are a promising candidate for the next generation of immunotherapy. However, in this setting, the antib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walters, Adam A., Santacana-Font, Gemma, Li, Jin, Routabi, Nadia, Qin, Yue, Claes, Nathalie, Bals, Sara, Tzu-Wen Wang, Julie, Al-Jamal, Khuloud T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613910/ https://www.ncbi.nlm.nih.gov/pubmed/34677938 http://dx.doi.org/10.1021/acsnano.1c04456

Ejemplares similares

Evaluation of cell surface reactive immuno-adjuvant in combination with immunogenic cell death inducing drug for in situ chemo-immunotherapy
por: Walters, Adam A., et al.
Publicado: (2020)

An “eat me” combinatory nano-formulation for systemic immunotherapy of solid tumors
por: Abdel-Bar, Hend Mohamed, et al.
Publicado: (2021)

Modulating expression of inhibitory and stimulatory immune ‘checkpoints’ using nanoparticulate-assisted nucleic acid delivery
por: Walters, Adam A, et al.
Publicado: (2021)

Anti-tumor antibody isotype response can be modified with locally administered immunoadjuvants
por: Walters, Adam A., et al.
Publicado: (2022)

Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
por: Jin, Jing, et al.
Publicado: (2020)

Engineering Nanoparticles to Reprogram the Tumor Immune Microenvironment for Improved Cancer Immunotherapy
por: Saeed, Madiha, et al.
Publicado: (2019)

In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy
por: Chariou, Paul L., et al.
Publicado: (2021)

Targeting focal adhesion kinase reprograms the pancreatic tumor microenvironment and renders pancreas cancer responsive to checkpoint immunotherapy
por: Jiang, Hong, et al.
Publicado: (2015)

In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice
por: Hodgins, Naomi O., et al.
Publicado: (2016)

Emerging phagocytosis checkpoints in cancer immunotherapy
por: Liu, Yu’e, et al.
Publicado: (2023)

In Situ Crosslinked Hydrogel Depot for Sustained Antibody Release Improves Immune Checkpoint Blockade Cancer Immunotherapy
por: Kim, Jihoon, et al.
Publicado: (2021)

The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy
por: Zhao, Huan, et al.
Publicado: (2018)

In situ reprogramming of gut bacteria by oral delivery
por: Hsu, Bryan B., et al.
Publicado: (2020)

Real-time monitoring of magnetic drug targeting using fibered confocal fluorescence microscopy
por: Bai, Jie, et al.
Publicado: (2016)

In-situ formed thermosensitive hydrogel amplifies statin-mediated immune checkpoint blockade for coordinated tumor chemo-immunotherapy
por: Liu, Zefan, et al.
Publicado: (2023)

Reversible Clustering of Gold Nanoparticles under Confinement
por: Sánchez‐Iglesias, Ana, et al.
Publicado: (2018)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Xu, Yaolin, et al.
Publicado: (2021)

Comparison between Fluorescence Imaging and Elemental Analysis to Determine Biodistribution of Inorganic Nanoparticles with Strong Light Absorption
por: Tamarov, Konstantin, et al.
Publicado: (2021)

Alternative Checkpoints as Targets for Immunotherapy
por: Pant, Ayush, et al.
Publicado: (2020)

Janus gold nanoparticles obtained via spontaneous binary polymer shell segregation
por: Percebom, Ana M., et al.
Publicado: (2016)

Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
por: Chen, Qian, et al.
Publicado: (2016)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
por: Payne, Kyle K., et al.
Publicado: (2012)

Cell Fate Reprogramming in the Era of Cancer Immunotherapy
por: Zimmermannova, Olga, et al.
Publicado: (2021)

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021)

Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy
por: Podojil, Joseph R., et al.
Publicado: (2022)

Investigating the effect of tumor vascularization on magnetic targeting in vivo using retrospective design of experiment
por: Mei, Kuo-Ching, et al.
Publicado: (2016)

Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
por: Qi, Jing, et al.
Publicado: (2021)

mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy
por: Li, Fengqiao, et al.
Publicado: (2023)

Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy
por: Hodgins, Naomi O., et al.
Publicado: (2017)

Immune checkpoints and immunotherapy for colorectal cancer
por: Singh, Preet Paul, et al.
Publicado: (2015)

Immune checkpoint signaling and cancer immunotherapy
por: He, Xing, et al.
Publicado: (2020)

NK Cell Dysfunction and Checkpoint Immunotherapy
por: Bi, Jiacheng, et al.
Publicado: (2019)

Resistance to Checkpoint Inhibition in Cancer Immunotherapy
por: Barrueto, Luisa, et al.
Publicado: (2020)

Diversity of immune checkpoints in cancer immunotherapy
por: Guo, Zhangyan, et al.
Publicado: (2023)

Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade
por: Zhang, Ying, et al.
Publicado: (2022)

Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy
por: Hassan, Hatem A.F.M., et al.
Publicado: (2016)

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
por: Scholtes, Mathijs P., et al.
Publicado: (2021)

Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming
por: Alvanou, Maria, et al.
Publicado: (2023)

Defining Reprogramming Checkpoints from Single-Cell Analyses of Induced Pluripotency
por: Tran, Khoa A., et al.
Publicado: (2019)

Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy
por: Yao, Yongrong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dimk5v02scr5cb1m3l6s8cufab